Roche Agenda For 2001 Includes Kytril NDA For Post-Op Use, Pegasys Launch
Roche plans to file an NDA during 2001 for use of the anti-emetic Kytril in post-operative nausea and vomiting, the company said during a recent analysts meeting in Basel.
Roche plans to file an NDA during 2001 for use of the anti-emetic Kytril in post-operative nausea and vomiting, the company said during a recent analysts meeting in Basel.